Human Health and Potential (HHP)

A*STAR researchers develop a standardised, self-administered taste and smell test for detecting the early symptoms of COVID-19.

A molecular tagging tool developed in Singapore identifies novel protein interactions on the surface of cancer cells.

A breakthrough discovery describes key molecular players involved in insulin secretion, paving the way for a new class of gene therapies targeting type 2 diabetes.

Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.

By looking at Peranakan Chinese genomes, researchers confirm the community arose from genetic mixing between local Malay women and foreign Chinese traders in the past.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.

Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.

Using a new nanomaterial, A*STAR researchers create a wound dressing that promotes healing and promises pain-free dressing changes for patients.

A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.

A computational model developed at A*STAR provides insights on how molecular dynamics of proteins impact their function, unlocking new precision medicine opportunities.

A novel molecular mechanism by which a malarial parasite enters host cells may broaden possibilities in malaria vaccine development.

The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.